Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
the role and mechanisms of receptor signalling in neuronal plasticity. The center of Excellence for “Protein in Memory” seeks to understand the molecular basis for memory with an emphasis on protein
-
innovative strategies to improve human health. HT is composed of five Centers: Health Data Science, Genomics, Computational Biology, Neurogenomics and Structural Biology. The Centers work together to enable
-
innovative strategies to improve human health. HT is composed of five Centers: Health Data Science, Genomics, Computational Biology, Neurogenomics and Structural Biology. The Centers work together to enable
-
The candidate will work on a project that aims to unravel the role of mechanical forces in maintaining and differentiating human embryonic stem cells. Specifically, the candidate will investigate how different
-
Biophysics) at Karolinska Institutet, Stockholm, Sweden). Your mission This interdisciplinary project leverages expertise in mitochondrial disease and molecular immunology to investigate the mechanisms and
-
Postdoctoral Research Associate - Basic and Translational Research Training in Pediatric Classical H
-malignant blood diseases, such as sickle cell disease, bone marrow failure syndromes, and myeloproliferative disorders. This premier NHLBI-sponsored T32 training program leverages the exceptional research
-
Postdoctoral Research Associate- Training in the Design & Development of Infectious Disease Therapeu
St. Jude is seeking outstanding candidates for postdoctoral fellowship positions in infectious disease therapeutics. This NIH sponsored training program has been designed to leverage the outstanding
-
the molecular mechanism that allows the transition zone (TZ), a conserved protein complex with unknown molecular structure, to maintain a specific lipid and protein composition in cilia. Cilia are evolutionary
-
, exacerbated by external stimuli such as UV radiation and mechanical stress. Current understanding and therapeutic strategies are limited due to inadequate human model systems capable of replicating
-
leukemia ( Nature Genetics 53:672, 2021) Described novel mechanisms driving therapy resistance to FDA-approved therapies in myeloid leukemia ( Cancer Discovery 13:170, 2023) Discovered a glutamine